
Seven Texas Retina Associates Physicians Earn New Professional Designation
The American Society of Retina Specialists has awarded its Fellow of the ASRS (FASRS) designation to the following Texas Retina Associates physicians: David Callanan, MD Rajiv Anand, MD Michel J. Shami, MD
read more
Ocular (Uveal) Melanoma and Biopsy – the “Why” and “How” of It
By Timothy Fuller, MD, Ocular Oncologist With the diagnosis of ocular (uveal) melanoma comes the very real risk of metastatic disease, or “spread” of the cancer to other parts of the body.
read more
Dr. Coors and Dr. Christopher Fuller Served as Invited Faculty for Retina LIVE! Surgical Case Series Event
Texas Retina Associates’ Lori E. Coors, MD, and Christopher G. Fuller, MD, joined speakers from Bascom Palmer Eye Institute, Stanford University’s Byers Eye Institute, and Duke University Eye Center as part of
read more
Dr. Abbey’s Research Published in Retina, the Journal of Retinal and Vitreous Diseases
Texas Retina Associates’ Ashkan Abbey, MD, has published research in the medical journal Retina. Titled “Refractive Outcomes After Sutureless Intrascleral Fixation of Intraocular Lens with Pars Plana Vitrectomy,” the results of his work
read more
Texas Retina Associates Participating in New Phase II Clinical Trial for Choroidal Melanoma
Texas Retina Associates is pleased to announce its participation in a groundbreaking new Phase II clinical trial for the treatment of small choroidal (ocular) melanoma. Together with Aura Biosciences, we are investigating
read more
North Dallas Office Moving to a New Suite
To better serve our patients, Texas Retina Associates will be moving our Dallas North office to a much larger suite within the same building. Opening Monday, July 6, 2020, the new Dallas
read more
We’re Smiling Behind Our Masks
The COVID-19 pandemic may have changed the way we look when you come into our offices, but it hasn’t changed the way we feel about all of our patients. We believe in
read more